In bladder cancer, TGF-β1 induces MALAT1 expression, whereas silencing of endogenous MALAT1 and its binding partner, SUZ12, suppresses TGF-β1-induced EMT [119]. Here, TGFB1 is linked to urinary bladder cancer.